Ann Dewitt

General Partnerat The Engine Funds· MA
Current roles
2
Investments attributed
15
Board seats
7
Form D directors and board-seat deals
As of · this person's identity; each section below carries its own date

4 additional roles and seats, 12 additional attributed investments

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 deal
    12 months

    1 investment attributed in the last 12 months; latest Terrestrial Bio Form D equity offering ($57.3M) on 19 Mar 2026.

    A partner with a recent deal is actively writing cheques now.

    Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →
Drawing the relationship network…

Roles

2 current, 0 past
  • The Engine Funds General Partner
    Jun 1, 2023 to present · “Schedule A: DEWITT, ANN, GENERAL PARTNER, since 06/2023, ownership NA, control person Y”
  • The Engine Accelerator, Inc. Partner
    Jan 1, 2018 to present · “Schedule A: DEWITT, ANN, PARTNER, since 01/2018, ownership NA, control person Y”

Investments attributed to this person

15
CompanyRoundInvestorAttributionDateSource
Terrestrial Bio, Inc.Form D equity offering · $57.3MThe Engine Accelerator, Inc.strongly supported · boardMar 19, 2026Inference sec.gov
Terrestrial Bio, Inc.board onlyThe Engine Accelerator, Inc.strongly supported · boardMay 28, 2024Inference sec.gov
Kano Therapeutics Inc.board onlyThe Engine Accelerator, Inc.strongly supported · boardMay 20, 2024Inference sec.gov

Board seats and vehicles

7 boards, 0 vehicles

Timeline

6 dated entries: events, attributed deals, board seats and role changes
  1. Mar 19, 2026
    Form D equity offering in Terrestrial Bio, Inc. (The Engine Accelerator, Inc.)
    Attributed investment Inference Terrestrial Bio, Inc. Form D
  2. May 28, 2024
    Board seat at Terrestrial Bio, Inc. (The Engine Accelerator, Inc.)
    Board seat Inference Terrestrial Bio, Inc. Form D
  3. May 20, 2024
    Board seat at Kano Therapeutics Inc. (The Engine Accelerator, Inc.)
    Board seat Inference Kano Therapeutics Inc. Form D
  4. Jun 1, 2023
    Joined The Engine Funds as General Partner
    Role began Fact The Engine Funds Form ADV
  5. Jan 1, 2018
    ANN Dewitt joined Schedule A of The Engine Accelerator, Inc. as Partner
Full timeline · 6 entriesnewest first
  1. Mar 19, 2026
    Form D equity offering in Terrestrial Bio, Inc. (The Engine Accelerator, Inc.)
    Attributed investment Inference Terrestrial Bio, Inc. Form D
  2. May 28, 2024
    Board seat at Terrestrial Bio, Inc. (The Engine Accelerator, Inc.)
    Board seat Inference Terrestrial Bio, Inc. Form D
  3. May 20, 2024
    Board seat at Kano Therapeutics Inc. (The Engine Accelerator, Inc.)
    Board seat Inference Kano Therapeutics Inc. Form D
  4. Jun 1, 2023
    Joined The Engine Funds as General Partner
    Role began Fact The Engine Funds Form ADV
  5. Jan 1, 2018
    ANN Dewitt joined Schedule A of The Engine Accelerator, Inc. as Partner
  6. Jan 1, 2018
    Joined The Engine Accelerator, Inc. as Partner

Record history

1 dated event on the change ledger, latest event first
  • Person joined
    2018-01-01source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.